Has David Goldberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,621,232 in general payments to David Goldberg, MD across 443 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Goldberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Goldberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Goldberg, MD

MOHS-Micrographic Surgery · Hackensack, NJNPI 1528001583

Payments from drug & device makers

$1,621,232in general payments, 2019–2025

Across 443 payments — averaging $3659.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$560K
H. Lundbeck A S$180K
Mindera Corp$124K
Sun Pharmaceutical Industries Inc.$123K
Galderma Laboratories, L.p.$120K
Sensus Healthcare, Inc.$92K
plus $424K from 41 others

$55,133in research payments, 2019–2025

Across 10 payments — averaging $5513.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Musculoskeletal Transplant Foundation Inc.$50K
Sensus Healthcare, Inc.$3K
AbbVie$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	96	$559,636
H. Lundbeck A S	22	$180,061
Mindera Corp	20	$123,770
Sun Pharmaceutical Industries Inc.	43	$123,109
Galderma Laboratories, L.p.	28	$119,502
Sensus Healthcare, Inc.	4	$91,597
Musculoskeletal Transplant Foundation Inc.	20	$85,691
Sweetbio, Inc.	6	$61,250
Eli Lilly	12	$48,958
Lumenis, Inc	2	$34,716
Bristol Myers Squibb	3	$30,264
Pfizer	21	$29,227
Amgen	6	$24,030
Janssen Research & Development, LLC	3	$21,868
Genentech, Inc.	7	$16,907
Biofrontera Inc.	9	$12,079
Regeneron	8	$10,250
Verrica Pharmaceuticals Inc.	3	$7,767
Merz North America, Inc.	15	$5,948
Solta Medical, A Division Of Bausch Health US, LLC	3	$4,283
Regeneron Healthcare Solutions, Inc.	10	$3,944
Ipsen Innovation	3	$3,515
Almirall LLC	10	$3,220
Mitsubishi Tanabe Pharma Development America, Inc.	3	$3,100
LEO Pharma Inc.	6	$3,034
Dermira, Inc.	3	$2,986
Incyte Corporation	6	$2,796
Revance Therapeutics, Inc.	2	$2,603
EPI Health, LLC	6	$1,677
Aclaris Therapeutics, Inc.	11	$1,488
Tanabe Pharma America, Inc.	1	$700
Organogenesis Inc.	7	$421
E.r. Squibb & Sons, L.L.C.	11	$200
Convatec Inc.	5	$117
Novartis	5	$100
Lilly USA, LLC	5	$84
Fidia Pharma USA Inc.	3	$60
VYNE Pharmaceuticals Inc.	3	$56
Sanofi	2	$39
Nobelpharma America, LLC	2	$37
Smith+Nephew	1	$31
Organon	2	$31
Kerecis Limited	1	$18
Arcutis Biotherapeutics, Inc.	1	$16
Kyowa Kirin, Inc.	1	$15
Genentech USA, Inc.	1	$15
Boehringer Ingelheim	1	$15

How this compares

$1,621,232 in reported general payments places this provider in the 95th percentile of 30 mohs-micrographic surgery providers in New Jersey.

See all mohs-micrographic surgery providers in New Jersey →

Medicare billing

Part B allowed, 2024

$311,832

Medicare patients

336

Services billed

1,456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other mohs-micrographic surgery in Hackensack

David CioconHackensack$938
Shikha RaoHackensack$402
Marc GlashoferWest Orange$175K
Kehua LiSewell$22K
Steven WangBasking Ridge$11K
John VinePrinceton$8K
Lian Jie LiPhillipsburg$7K
David NajarianRandolph$5K
Parth PatelBridgewater$4K
Shreya PatelWest Orange$3K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →